Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk-Reference-Cited by-同舟云学术

Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk

Published:2022-02-11 Issue:4 Volume:25 Page:362-368
ISSN:1369-7137
Container-title:Climacteric
language:en
Short-container-title:Climacteric

Author:

Tan D. A.¹,Dayu A. R. B.¹

Affiliation:

1. Section of Reproductive Medicine, Department of Obstetrics and Gynecology, St. Luke’s Medical Center – Quezon City, Quezon City, Philippines

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13697137.2022.2035711

Reference66 articles.

1. Women's perception of the menopause and hormone treatment: barriers against hormone therapy

2. NHLBI Communications Office. NHLBI Stops Trial of Estrogen Plus Progestin Due to Increased Breast Cancer Risk, Lack of Overall Benefit. July 8, 2002. http://www.nhlbi.nih.gov/new/press/02-07-09.htm.

3. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

4. Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women

5. Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone Replacement Therapy (HRT) Shortages for Treating Menopause: What Can Clinicians Do to Relieve Symptoms and Concerns?;Sci;2024-08-02

2. Quality of life in heterosexual menopausal women: The indirect effect of sexual and marital satisfaction, menopause representations, and psychological morbidity;Health Care for Women International;2023-09-05

3. Care, choice, complexities: The circulations of hormone therapy in early menopause;The Sociological Review;2023-06-15

4. Climacteric patient in office of general practitioner;Medicína pro praxi;2023-06-15

5. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context;Menopause;2023-01-22